Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127904351 | 12790435 | 1 | I | 2005 | 20080923 | 20160929 | 20160929 | PER | US-ASTRAZENECA-2008BM13590 | ASTRAZENECA | 54.00 | YR | F | Y | 86.20000 | KG | 20160929 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127904351 | 12790435 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | U | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | ||||||
| 127904351 | 12790435 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | U | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | ||||||
| 127904351 | 12790435 | 3 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | U | A404197 | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||
| 127904351 | 12790435 | 4 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | U | A533578A | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||
| 127904351 | 12790435 | 5 | SS | BYDUREON | EXENATIDE | 1 | Subcutaneous | 0 | 2 | MG | /wk | ||||||||
| 127904351 | 12790435 | 6 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | EITHER 20 MG OR 2.5 MG, DAILY | 0 | TABLET | |||||||||
| 127904351 | 12790435 | 7 | C | GLYBURIDE. | GLYBURIDE | 1 | UNK | 0 | |||||||||||
| 127904351 | 12790435 | 8 | C | GLUCOPHAGE /USA/ | 2 | UNK | 0 | ||||||||||||
| 127904351 | 12790435 | 9 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 4 | DF | QD | ||||||||
| 127904351 | 12790435 | 10 | C | GLIPIZIDE. | GLIPIZIDE | 1 | Oral | 0 | 2 | DF | QD | ||||||||
| 127904351 | 12790435 | 11 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 127904351 | 12790435 | 12 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 127904351 | 12790435 | 13 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | EITHER 20 MG THE OTHER IS 2.5 MG,DAILY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127904351 | 12790435 | 1 | Type 2 diabetes mellitus |
| 127904351 | 12790435 | 2 | Type 2 diabetes mellitus |
| 127904351 | 12790435 | 3 | Type 2 diabetes mellitus |
| 127904351 | 12790435 | 4 | Type 2 diabetes mellitus |
| 127904351 | 12790435 | 5 | Type 2 diabetes mellitus |
| 127904351 | 12790435 | 6 | Hypertension |
| 127904351 | 12790435 | 7 | Type 2 diabetes mellitus |
| 127904351 | 12790435 | 8 | Type 2 diabetes mellitus |
| 127904351 | 12790435 | 9 | Type 2 diabetes mellitus |
| 127904351 | 12790435 | 10 | Type 2 diabetes mellitus |
| 127904351 | 12790435 | 11 | Depression |
| 127904351 | 12790435 | 12 | Ill-defined disorder |
| 127904351 | 12790435 | 13 | Blood cholesterol increased |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127904351 | 12790435 | Blood glucose decreased | |
| 127904351 | 12790435 | Blood glucose increased | |
| 127904351 | 12790435 | Headache | |
| 127904351 | 12790435 | Hypotension | |
| 127904351 | 12790435 | Injection site haemorrhage | |
| 127904351 | 12790435 | Injection site pain | |
| 127904351 | 12790435 | Intentional product misuse | |
| 127904351 | 12790435 | Malaise | |
| 127904351 | 12790435 | Memory impairment | |
| 127904351 | 12790435 | Nausea | |
| 127904351 | 12790435 | Tremor | |
| 127904351 | 12790435 | Urinary tract infection | |
| 127904351 | 12790435 | Vomiting | |
| 127904351 | 12790435 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127904351 | 12790435 | 1 | 2005 | 2005 | 0 | |
| 127904351 | 12790435 | 2 | 2005 | 2005 | 0 | |
| 127904351 | 12790435 | 3 | 2005 | 0 | ||
| 127904351 | 12790435 | 4 | 2009 | 0 | ||
| 127904351 | 12790435 | 5 | 2016 | 0 | ||
| 127904351 | 12790435 | 10 | 201601 | 0 |